Eamonn Hobbs

Form D signer

Eamonn Hobbs

Chief Executive Officer at Syncromune

Form D signer

Capital raised by Syncromune

$144.8M+$144.8M latest round

1 Form D filing · first filed Dec 2024 · Fort Lauderdale, FL

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: —

Career

1 company on file

SyncromuneBiotech · Fort Lauderdale, FLsince Dec 2024

Chief Executive Officer

Signatory on Syncromune's Form D filings · $144.8M raised across 1

Company filings

via EDGAR · Form D for Syncromune1

DateCompanyFormAmountRole on filing

Dec 3, 2024SyncromuneForm D/A+$144.8MChief Executive Officer

Form D/ADec 3, 2024 · Syncromune+$144.8Mas Chief Executive Officer

Overview

Last filing Dec 3, 2024

Eamonn Hobbs is on file as Chief Executive Officer at Syncromune in Fort Lauderdale, FL. Syncromune has 1 Form D filing on record, $144.8M raised in total. Eamonn Hobbs appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Syncromune · 1

Stephen DaleExecutive Officer

Products

Syncromune · 1

SYNC-T Therapy SV-102Clinical-stage oncology therapeutic

An investigational in situ combination immunotherapy for metastatic castration-resistant prostate cancer that pairs tumor cryoablation with an intratumoral multi-target biologic, currently in the LEGION-100 Phase 2 clinical trial.